Unfortunately, war is the daily media lead. We get the numbers of dead and injured for each conflict. You might consider those just injured as ‘lucky’ if you’re like me. Au contraire. Familiar issues are traumatic brain and spine injuries. Alongside lost limbs and wounds caused by bomb debris and emotional symptoms such as PTSD and depression that may persist for years, sometimes a lifetime. (Xaigham.com)
For life-saving technologies, war has unfortunately become a growth sector. I take no pleasure in saying that.
A sudden, traumatic blow to the spine (tSCI) can fracture, dislocate, crush or compress one or more of the vertebrae. A gunshot or knife wound that penetrates and cuts the spinal cord also can cause a spinal cord injury. Additional damage usually occurs over days or weeks.
The global Spinal Cord Trauma Treatment market was valued at US$ 2458.9 million in 2022 and is projected to reach US$ 3009.4 million by 2029, at a CAGR of 2.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The current Middle East conflict was not included. Unfortunately, those projected growth numbers could rise significantly.
While I am using the wars and conflicts as examples of the growth of the traumatic injury market, it was already significant and this is just the US.
The question arises: how is this issue addressed? There are myriad companies, large and small, looking for answers.
TORONTO and HAIFA, Israel, Jan. 05, 2024 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (TSXV: NRX) (FSE: J90) (NRX.V) (the “Company” or “NurExone”), a biopharmaceutical company developing biologically-guided exosome therapy for patients with traumatic spinal cord injuries.
How does it work? Stay with me; it’s pretty straightforward.
Part One: Active Ingredients
Exosomes: Exosomes, also known as extracellular vesicles, are nano-sized, naturally occurring particles in the body, secreted by cells. Exosomes, also known as extracellular vesicles, are nano-sized, naturally occurring particles in the body, secreted by cells. Can be administered non-invasively, intranasally
Part Two: Delivery
ExoTherapy: Exosomes, loaded with therapeutic molecules, cross the blood-brain barrier and reach cells and tissues for regeneration, rewiring and recovery.
Part Three: Effect
SiRNA-PTEN: The suggested PTEN inhibition-based therapeutic targets are nerve growth and regeneration after injury or damage, treatment of cardiac ischemia/reperfusion and associated disease, wound repair, and infertility.
The goal is to reverse this traumatic brain trauma as well as develop other health issues such as depression—no small accomplishment. The US FDA has granted NRX Orphan Drug Status.
The Orphan Drug Designation program provides orphan status to drugs and biologics for rare diseases that meet specific criteria. Orphan drug designation provides incentives, including:
“Orphan-drug designation is expected to streamline our go-to-market, shorten our regulatory process, save the Company millions of dollars, and provide valuable market exclusivity. We appreciate the formal recognition of the potential impact of our therapy on the lives of patients suffering from acute spinal cord injuries,” said Dr. Shaltiel, CEO of NurExone Biologic, Ltd.
The Company also holds an exclusive worldwide license from Technion and Tel Aviv University for developing and commercializing the technology.
This technology is not only promising but appears well destined for success. In their totality, the current NRX out-front therapies could bring much relief to those seriously ‘injured’ patients who live with chronic pain and myriad challenges daily.
NurExome is a cutting-edge medical technology company. While trading has been modest, it paints a positive investment picture for the previously reasons stated. Will it pop tomorrow? No. That I can guarantee.
A savvy plan would to be to approach as a dollar-cost average investment. The deeper you dig, the more potential will become apparent.
Note Hyperlinks below.
Stock stats Jan 5 2024 | |
52 Week Range | 0.1000 0.4200 |
Volume | 7,000 |
Avg. Volume | 4,511 |
Market Cap | 14.475M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.1100 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 4.01 |
In-depth Corporate Presentation Litchfield Research |
TraceSafe Inc. (CSE: TSF) (“TraceSafe”) is a global leader in location-aware Internet of Things (IoT) platforms for large-scale industrial and enterprise operations.
The Company pivoted from providing IoT wearables solutions to providing Carbon Solutions. Knowledge gained in the wearables space has efficacy in the Smart Cities and Carbon Space.
A Smart City is a technologically modern urban area that uses different types of electronic methods and sensors to collect specific data. The information gained from that data is used to manage assets, resources and services efficiently; that data is used to improve operations across the city.
Carbon space is the amount of carbon (or CO2) that can be put into the atmosphere without this leading to a level of warming—or underlying concentrations of CO2—that can be considered dangerous or otherwise undesirable.
Wayne Lloyd, the TraceSafe CEO, stated, “Organizations are being driven to decarbonize by all major stakeholders, yet they aren’t able to reliably measure their emissions or access efficient decarbonization opportunities. With ShiftCarbon, our vision was to offer solutions that would help customers address their immediate needs, irrespective of where they stand in their net-zero journey,” Organizational climate goals cannot be met overnight. Still, with intelligent innovations, we are optimistic that they can be accelerated. Leaders who embrace our solution now will be able to drive sustainable growth for their organizations and a sustainable future for the planet.”
One large sector that has been looking for ways to slash emissions is the Cruise business. TraceSafe, a tech startup, boasts large clients such as Royal Caribbean(RCL: NYSE) and Viking Cruises (private), which has the technology to decarbonize the big ships with its novel carbon capture technology.
Vancouver-based tech TraceSafe(TSF: CSE) already has contracts with large enterprise customers like Royal Caribbean and Viking Cruises. TraceSafe has already developed custom wearables for passengers and employees aboard their ships, giving it a competitive edge for the deployment of its Carbon reduction applications.
“It was the willingness of the TraceSafe team to develop a custom Tracelet™ device that met our requirements for style and design that propelled the partnership forward,” said Jay Schneider, SVP and Chief Innovation Officer (CXO) at Royal Caribbean. “We look forward to continuing this engagement with TraceSafe as we explore the many new IoT technology opportunities onboard our ships*.”*
Current Use Cases for Bracelets onboard:
Carbon, Carbon, Everywhere.
Ships emit ~1 billion tonnes of greenhouse gas yearly, more than airplanes. The transportation industry is responsible for 25 percent of GGE; airplanes alone are 12 percent.
The new International Maritime Organization (IMO) regulations require the shipping industry to cut emissions by 40% by 2023.
New Maritime regulations drive changes in the shipping and cruise industry to reduce emissions. Traditionally, the Maritime industry is very dependent on Fossil fuels. Unlike Electric Cars, the near-term solution does not currently exist for large vessels due to the energy requirements to transport large volumes of goods over long distances.
TraceSafe’s New ShiftCarbon Solution
ShiftCarbon is the company’s biggest launch since its award-winning platform for enterprise safety, AllSafe. ShiftCarbon will consolidate critical climate data for SMBs and help them reduce their carbon footprint using high-quality offsets. It is a highly modular platform built to support organizations wherever they are in their journey toward carbon neutrality and net zero. ShiftCarbon will enable:
In addition to ShiftCarbon, TraceSafe has launched ThermoSense- a sensor-based approach to a sustainable supply chain, followed by the acquisition of Offsety- a carbon offset marketplace for managed decarbonization and most recently, the launch of its events emissions calculator that will help global sporting events reach net-zero faster.
Carbon Capture Technology Aboard Oceanliners
Summary
We believe that ESG trends within the Maritime Industry, coupled with TraceSafe’s existing customers, such as Royal Caribbean and Viking, puts them in a superior position to secure new clients and upsell to their existing customers.
©2024 10xAlerts